Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Nov;30(2):572–577. doi: 10.1128/iai.30.2.572-577.1980

Preparation and characterization of rabies virus hemagglutinin.

J H Cox, B Dietzschold, F Weiland, L G Schneider
PMCID: PMC551349  PMID: 7439995

Abstract

Rabies virus glycoprotein, released by treatment with Triton X-100, was isoelectrically focused in a sucrose gradient containing the nonionic detergent octylglucoside. Removal of the detergent by dialysis resulted in aggregates of variable size and shape. The hemagglutinating activity of this preparation was approximately sixfold higher than that of the intact virus. The protein with hemagglutinating activity and with a buoyant density of 1.237 consisted solely of polypeptide chains of the G-protein and contained 0.38% phospholipids and 16 ng of Triton X-100 per mg of protein. In the National Institutes of Health test the hemagglutinin conferred a significantly higher protective activity than detergent-associated glycoprotein and was as effective as an inactivated virus vaccine. However, after the application of a single dose of hemagglutinin, the onset of protection was delayed by approximately 7 days when compared with inactivated virus vaccine.

Full text

PDF
572

Images in this article

574Fig. 2
on p.574
575Fig. 4
on p.575
576Fig. 5
on p.576

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron C., Thompson T. E. Solubilization of bacterial membrane proteins using alkyl glucosides and dioctanoyl phosphatidylcholine. Biochim Biophys Acta. 1975 Mar 25;382(3):276–285. doi: 10.1016/0005-2736(75)90270-9. [DOI] [PubMed] [Google Scholar]
  2. Bramhall S., Noack N., Wu M., Loewenberg J. R. A simple colorimetric method for determination of protein. Anal Biochem. 1969 Oct 1;31(1):146–148. doi: 10.1016/0003-2697(69)90251-6. [DOI] [PubMed] [Google Scholar]
  3. Cox J. H., Dietzschold B., Schneider L. G. Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun. 1977 Jun;16(3):754–759. doi: 10.1128/iai.16.3.754-759.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cox J. H., Schneider L. G. Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine. J Clin Microbiol. 1976 Feb;3(2):96–101. doi: 10.1128/jcm.3.2.96-101.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dietzschold B., Cox J. H., Schneider L. G., Wiktor T. J., Koprowski H. Isolation and purification of a polymeric form of the glycoprotein of rabies virus. J Gen Virol. 1978 Jul;40(1):131–139. doi: 10.1099/0022-1317-40-1-131. [DOI] [PubMed] [Google Scholar]
  6. Dietzschold B. Oligosaccharides of the glycoprotein of rabies virus. J Virol. 1977 Aug;23(2):286–293. doi: 10.1128/jvi.23.2.286-293.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  8. Halonen P. E., Murphy F. A., Fields B. N., Reese D. R. Hemagglutinin of rabies and some other bullet-shaped viruses. Proc Soc Exp Biol Med. 1968 Apr;127(4):1037–1042. doi: 10.3181/00379727-127-32864. [DOI] [PubMed] [Google Scholar]
  9. Helenius A., von Bonsdorff C. H. Semlike Forest virus membrane proteins. Preparation and characterization of spike complexes soluble in detergent-free medium. Biochim Biophys Acta. 1976 Jul 15;436(4):895–899. doi: 10.1016/0005-2736(76)90421-1. [DOI] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Lorenz R. J., Bögel K. Laboratory techniques in rabies: methods of calculation. Monogr Ser World Health Organ. 1973;(23):321–335. [PubMed] [Google Scholar]
  12. Miller D. K., Feuer B. I., Vanderoef R., Lenard J. Reconstituted G protein-lipid vesicles from vesicular stomatitis virus and their inhibition of VSV infection. J Cell Biol. 1980 Feb;84(2):421–429. doi: 10.1083/jcb.84.2.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. STOKER M., MACPHERSON I. SYRIAN HAMSTER FIBROBLAST CELL LINE BHK21 AND ITS DERIVATIVES. Nature. 1964 Sep 26;203:1355–1357. doi: 10.1038/2031355a0. [DOI] [PubMed] [Google Scholar]
  14. Schlumberger H. D., Schneider L. G., Kulas H. P., Diringer H. Gross chemical composition of strain Flury HEP rabies virus. Z Naturforsch C. 1973 Jan-Feb;28(1):103–104. [PubMed] [Google Scholar]
  15. Schneider J., Schwarz H., Hunsmann G. Rosettes from Friend leukemia virus envelope: preparation and physicochemical and partial biological characterization. J Virol. 1979 Feb;29(2):624–632. doi: 10.1128/jvi.29.2.624-632.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wiktor T. J., Dietzschold B., Leamnson R. N., Koprowski H. Induction and biological properties of defective interfering particles of rabies virus. J Virol. 1977 Feb;21(2):626–635. doi: 10.1128/jvi.21.2.626-635.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES